XNASUTMD
Market cap210mUSD
Jan 16, Last price
61.99USD
1D
-1.40%
1Q
-6.50%
Jan 2017
-14.79%
Name
Utah Medical Products Inc
Chart & Performance
Profile
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 50,224 -3.93% | 52,281 6.58% | |||||||
Cost of revenue | 33,447 | 32,491 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 16,777 | 19,790 | |||||||
NOPBT Margin | 33.40% | 37.85% | |||||||
Operating Taxes | 3,454 | 4,186 | |||||||
Tax Rate | 20.59% | 21.15% | |||||||
NOPAT | 13,323 | 15,604 | |||||||
Net income | 16,635 0.98% | 16,473 11.39% | |||||||
Dividends | (4,282) | (3,163) | |||||||
Dividend yield | 1.40% | 0.86% | |||||||
Proceeds from repurchase of equity | (2,378) | (2,321) | |||||||
BB yield | 0.78% | 0.63% | |||||||
Debt | |||||||||
Debt current | 54 | ||||||||
Long-term debt | 590 | 682 | |||||||
Deferred revenue | 549 | ||||||||
Other long-term liabilities | 698 | 1,463 | |||||||
Net debt | (92,278) | (74,316) | |||||||
Cash flow | |||||||||
Cash from operating activities | 22,281 | 21,147 | |||||||
CAPEX | (639) | (818) | |||||||
Cash from investing activities | (639) | (818) | |||||||
Cash from financing activities | (4,165) | (5,484) | |||||||
FCF | 13,541 | 15,445 | |||||||
Balance | |||||||||
Cash | 92,868 | 75,052 | |||||||
Long term investments | |||||||||
Excess cash | 90,357 | 72,438 | |||||||
Stockholders' equity | 127,719 | 114,003 | |||||||
Invested Capital | 38,949 | 43,792 | |||||||
ROIC | 32.20% | 32.87% | |||||||
ROCE | 12.83% | 16.81% | |||||||
EV | |||||||||
Common stock shares outstanding | 3,637 | 3,643 | |||||||
Price | 84.22 -16.22% | 100.53 0.53% | |||||||
Market cap | 306,308 -16.36% | 366,231 0.06% | |||||||
EV | 214,030 | 291,915 | |||||||
EBITDA | 23,145 | 26,872 | |||||||
EV/EBITDA | 9.25 | 10.86 | |||||||
Interest | 869 | ||||||||
Interest/NOPBT | 4.39% |